FIELD: medicine. SUBSTANCE: method involves precipitation of globulins of serum blood, the process is carried out with the help of ammonium sulfate. Sufficient amount of probe solution is added into supernatant liquid. Intensity of luminescence is registered at wavelength being equal to 540 nm. If said intensity of luminescence decreased then therapy is considered to be effective. EFFECT: enables estimation of efficiency of therapy at its early stages, improves efficiency of the method.
| Title | Year | Author | Number |
|---|---|---|---|
| EARLY DIAGNOSTIC TECHNIQUE FOR CHRONIC RENAL DISEASE | 2013 |
|
RU2566709C2 |
| ENTEROSORBENT FOR TREATING RENAL INSUFFICIENCY | 1994 |
|
RU2097046C1 |
| RECOMBINANT DNA pA3, RECOMBINANT DNA pQE 30-pA3 PROVIDING PRODUCING POLYPEPTIDE A3, STRAIN E. coli M 15-A3 TRANSFORMED BY RECOMBINANT PLASMID DNA pQE 30-pA3 AND EXPRESSING RECOMBINANT POLYPEPTIDE A3, RECOMBINANT POLYPEPTIDE A3 POSSESSING ABILITY TO BIND HUMAN SERUM ALBUMIN, AND RFA TEST SYSTEM FOR QUALITATIVE DETECTION OF MICROALBUMINURIA, TEST SYSTEM FOR QUANTITATIVE DETERMINATION OF MICROALBUMINURIA | 2013 |
|
RU2550255C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CHRONIC RENAL INSUFFICIENCY IN CONGENITAL URINOGENITAL MALFORMATIONS | 2010 |
|
RU2422826C1 |
| METHOD FOR DIAGNOSING ENDOGENOUS INTOXICATION SYNDROME GRAVITY DEGREE IN CHRONIC RENAL INSUFFICIENCY PATIENTS | 2004 |
|
RU2276366C1 |
| METHOD PREDICTING CHRONIC RENAL INSUFFICIENCY AT PATIENTS WITH POSTCAPILLAROTOXIC GLOMERULONEPHRITIS | 2007 |
|
RU2333497C1 |
| METHOD FOR PREVENTING RENAL DAMAGE IN PATIENTS WITH A PRIMARILY IDENTIFIED SECRETING MULTIPLE MYELOMA | 2017 |
|
RU2652082C1 |
| METHOD OF DETERMINING MODIFIED ALBUMIN IN THE BLOOD OF A MAN | 0 |
|
SU1772744A1 |
| METHOD FOR DETERMINING OBJECTIVE INDICATIONS FOR DISINTOXICATION THERAPY IN CHILDREN WITH INFECTIOUS DISEASES | 2011 |
|
RU2462712C1 |
| METHOD FOR APPLYING RESTORATION THERAPY TO CHRONIC PYELONEPHRITIS PATIENTS | 2003 |
|
RU2250771C2 |
